Intramolecular hydrogen bonding (IMHB) considerations are gaining relevance in drug discovery and a molecular descriptor which can predict very early the capacity of a compound to form IMHB is needed to speed up the optimization process of drug candidates.
Preface
Lipophilicity represents the affinity of a molecule or a moiety for a lipophilic environment. It is commonly measured by the partition coefficient P defined as the ratio between the concentration of the solute in the partition solvent (immiscible with water) and its concentration in water [1] . Octanol is considered the partition solvent by most researchers in drug discovery thus log Poct is often simply written as log P. Here the partition solvent will be explicitly indicated in subscript since more solvents and thus more log Ps will be discussed in the paper. The second descriptor of lipophilicity is the distribution coefficient, expressed as D pH , and its logarithm (log D pH ). It is a pH dependent descriptor for ionizable solutes and results from the weighted contributions of all ionised forms present at the indicated pH [1] . Since in this study we refer to neutral compounds, log Poct = log D pH oct all along the manuscript.
log P oct : an established tool in drug discovery
The role of lipophilicity descriptors in determining the overall quality of drug candidates is of paramount importance [2] and in fact log P is implemented in the Lipinski's rule of five (Ro5) [3] . The Ro5 states that an orally active drug has no more than one violation of the following criteria: no more than 5 hydrogen bond donors (HBD, the total number of nitrogen-hydrogen and oxygen-hydrogen bonds), no more than 10 hydrogen bond acceptors (HBA, all nitrogen or oxygen atoms), a molecular mass less than 500 Daltons and a log Poct not greater than 5. To identify opportunities for oral drug discovery beyond the Ro5 (bRo5), it has been suggested that oral druggable space bRo5 may extend up to a log Poct of 6 [4] .
In addition to implementation in the Ro5, log Poct is also applied as indicators of project progresses through the lipophilicity efficiency (LipE) equation [5] . The concept of LipE allows medicinal chemists to normalize the observed potency with changes in lipophilicity and thus LipE is used in the evaluation of specific structural modifications during the progression of a chemical series (e.g. the development of homologues).
Finally, increasing lipophilicity is one of the potential approaches used by many medicinal chemists to improve passive permeability (an example is discussed in [6] ), whereas the hERG-mediated cardiovascular liability is traditionally avoided by lowering lipophilicity and eliminating basic amine functionality (for instance as discussed by Dow [7] ). Lipophilicity modulation is also applied to limit metabolism issues.
Summing up, the role of lipophilicity in determining the overall quality of drug candidates is well established and log Poct and log Doct are routinely used in drug discovery programs for optimization purposes.
log P oct and IMHB
An intramolecular hydrogen bond (IMHB) occurs when a hydrogen bond (HB) is formed between a hydrogen bond donor (HBD) and a hydrogen bond acceptor (HBA) that belong to the same molecule ( Figure 1 ). pag. 3
Figure 1. A molecule with a hydrogen donor group HBD (D-H) and a hydrogen bond acceptor group HBA (A) can exist in two forms A) open (extended)
, in which the HBA and HBD moieties are exposed and B) closed (folded), in which an IMHB is formed and masks the HB properties of the HBA and HBD moieties.
Giordanetto and other researchers recently figured out the formation or disruption IMHB as one valuable strategy to transform molecules into drugs [8] and suggested to include IMHB considerations in drug discovery programs [9] . In fact, IMHB could improve cell permeability and oral bioavailability without necessarily decreasing solubility and binding affinity [10] [11] [12] . For practical purposes it is therefore important to find a descriptor (i.e. a number) which quantifies how easily a molecule can form IMHBs.
In principle, lipophilicity in octanol/water could be used to describe the propensity of compounds to form IMHBs since the formation of IMHBs is expected to mask the polarity of the HBA and HBD moieties ( Figure 1 ) and thus increase log Poct.
However, log Poct is not a convenient choice to assess IMHB properties. This is revealed by a Quantitative Structure-Property Relationship (QSPR) where log Poct was related to a set of Volsurf+ descriptors (https://www.moldiscovery.com/) by a Partial Least Square (PLS) algorithm and the final model was analysed using the BR analysis [13] . Shortly, BR analysis shows in one picture (see Fig. 2A for the meaning of the graphs at a glance) the molecular features (e.g. solutes dimensions and HB properties) governing log Poct : blocks with positive weighting (e.g. the green block) increase log Poct (the higher, the more), whereas those with negative weighting indicate how much the property decreases log Poct (the lower, the less). Moreover, blocks with comparable positive and negative contributions are poorly relevant in the description of log Poct. From BR analysis one can appreciate the dominant impact of the green Size/Shape block (from here on called Size) which is the major limit in the use of log Poct as a tool for IMHB considerations. In fact, log Poct mostly depends on solutes' dimensions rather than HB properties, the red and the blue blocks in Fig BR analysis also highlights a second limit of log Poct as a tool for IMHB considerations. Fig. 2A shows that the red block (HBD properties) is split in two components with opposite sign. This means that H-bond donor groups do not force compounds to stay in the aqueous phase but instead they support an equal partition into octanol and water. Therefore, the formation of an IMHB which mostly reduces HDB properties exposure does not have a strong impact on log Poct. [13] , B) log Ptol [13] and C) ∆logPoct-tol [14] . 
Figure 2. Some examples of BR analysis output : A) log Poct

Going beyond octanol/water and combining log Ps
In the previous section we highlighted that log Poct is not the best tool for IMHB considerations. From BR analysis one could reason to replace octanol/water with a biphasic system in which the Size contribution is less important whereas HBD and HBA blocks are more important. Such a system could be more sensible to characterize the propensity of compounds to form IMHBs.
Log Ptol, the logarithm of the partition coefficient P in the toluene/water system was recently introduced in drug discovery by Shalaeva and coworkers [9] . BR analysis (Fig. 2B) a major impact of the HB-related blocks (both the red and the blue blocks are larger) but not a significative decrease of the Size (green block) which remains the most important block.
To limit the impact of Size, a difference between log Ps is expected to provide good results and in fact ∆log Pocttol (i.e. the difference between log Poct and log Ptol) is a clean descriptor of exposed HBD properties [9] . BR analysis supports this expectancy (Fig. 2C) showing that ∆log Poct-tol is mostly influenced by HBD solutes' property (red block, positive sign) and it is poorly influenced by steric descriptors (green block, negative sign) [14] . The presence of IMHBs thus produces low ∆log Poct-tol values.
Case studies
As discussed above, the major impact of Size prevents log Poct values from providing clean information about the propensity of compounds to form IMHB and a trick to overpass this issue is pair analysis. This consists in comparing a sample with a substructure prone to IMHB formation along with a control compound with similar structure (and thus Size) but incapable of forming that bond. Two examples are discussed below.
In the first example, we pay our attention on the couple of compounds 3a and 3b ( Figure 3A ) reported in the literature by Kuhn and coworkers [15] . 3b shows a substructure prone to IMHB formation whereas 3a (the control) is a compound incapable of forming that bond since a hydrogen atom is substituted by a more lipophilic methyl group. Crystallographic data supported the presence of an IMHB in 3b. Despite the presence of the N-methyl substituent, log Poct of 3a (0.68) is lower than log Poct of 3b (1.39). In 3b the presence of an IMHB reduces the polarity of the amide and the imidazole N-H and this is revealed by the increase in experimental log Poct. In this case log Poct is in line with NMR data and supports the presence of the IMHB.
In the second example, we focus on compounds 1 (the sample) and 2 (the control). Their chemical structures are in Fig. 3B [16] . EPSA, a supercritical fluid chromatography method specifically developed for the detection of IMHB [17] , showed that 1 forms an IMHB. The lipophilicity in octanol/water was described by ElogD, a widely known and validated chromatographic surrogate of log Doct [18] . ElogD is 0.9 for 1 and 0.8 for 2. These data suggest that two regioisomers 1 and 2 show the same lipophilicity in the octanol/water system and thus this evidence does not support the presence/absence of the IMHB experimentally revealed by another experimental approach. pag. 6 Due to the laboriousness of the experimental measurements, log Poct values are often assessed through calculators. Furthermore, this option is mandatory in very early drug discovery when dealing with virtual structures. A plethora of both commercial and free tools can do that [19] . However, one should be aware that most log Poct calculators are 2D tools and thus cannot be used for investigating IMHB formation which is conformation-dependent. An example is provided by Bockus and coworkers who synthetized a series of cyclic hexapeptide diastereomers containing γ-amino acids and determined lipophilicity and permeability properties [20] . Two compounds c2 and c4 are in Fig. 3C and Overall, examples in Fig. 3 support BR analysis results and show that log Poct is not the most effective tool to predict the capacity of compounds to form IMHBs since log Poct can reveal the presence of some but not all IMHBs. Therefore, its application in drug discovery should be supported by additional descriptors. As discussed above, BR analysis designates ∆log Poct-tol as a pure descriptor of HBD properties. Therefore, if
∆log Poct-tol can be experimentally obtained (solubility issues can limit the determination of log Ptol), it can be used to predict the propensity of compounds to form IMHBs. Some examples are discussed below.
When a compound has a single HBD group (and at least one HBA), the application of ∆log Poct-tol is straightforward. If ∆log Poct-tol is close to 0 then the compound has high propensity to form IMHBs since this means that the contribution of the red block (i.e. HBD properties) is neglected. This was recently shown by some of us using 1 (Figure 4A , ∆log Poct-tol = 0.10) as an example [9] . The interpretation of ∆log Poct-tol is more complex when more HBD groups are present in the chemical structure.
Nelfinavir (Fig. 4B) is a protease inhibitor which shows a molecular property profile that is generally considered to be disadvantageous for the membrane permeability and drug absorption [21] . It is therefore important to Overall, these examples support that ∆log Poct-tol is a valuable tool to experimentally assess information about IMHB formation. In many cases, from the numerical value researchers can direct evaluate the skill of compounds to form IMHBs. For complex structures, standard conformational analysis can help ∆log Poct-tol interpretation.
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Conclusions
Despite its wide application in research programs, the potential of lipophilicity as an elucidator of structural properties is not fully exploited. In this paper we showed that for a more efficient use of lipophilicity in IMHB considerations, the determination of log Poct is not sufficient. Indeed, we need to go beyond the traditional octanol/water system, set-up a second system with a more apolar organic phase (i.e. toluene/water) and calculate ∆log Poct-tol. This latter can provide a significant amount of information about IMHB formation and be used in early drug discovery.
